Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate

Background The objective of this study was to validate an animal model for dry eye during and after the administration of 1% ophthalmic atropine sulfate (OAS) in New Zealand white (NZW) rabbits. Methods OAS (1%) was applied three times per day to 30 eyes of 15 healthy NZW rabbits. Sacrifice, enuclea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Animal Models and Experimental Medicine 2022-09, Vol.5 (3), p.266-273
Hauptverfasser: Sánchez‐Ríos, Alejandra, Correa‐Gallegos, Elba Yadira, Medina‐Espinoza, José Manuel, Navarro‐Sanchez, Andrea Anaid, Olvera‐Montaño, Oscar, Baiza‐Durán, Leopoldo, Muñoz‐Villegas, Patricia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The objective of this study was to validate an animal model for dry eye during and after the administration of 1% ophthalmic atropine sulfate (OAS) in New Zealand white (NZW) rabbits. Methods OAS (1%) was applied three times per day to 30 eyes of 15 healthy NZW rabbits. Sacrifice, enucleation, and lacrimal gland removal took place on days 15, 21, and 30 (OAS group). A second group (n = 5) was used as control. Clinical evaluations took place on days 3, 10, 15, 18, 21, 24 and 30. The primary endpoints were: Schirmer I test, tear break‐up time (TBUT), and corneal fluorescein staining. As secondary endpoints, clinical changes including intraocular pressure, and histopathology were evaluated. Results While OAS was administered, the Schirmer I test showed a statistically significant reduction for OAS group versus control (p 
ISSN:2576-2095
2096-5451
2576-2095
DOI:10.1002/ame2.12218